duetact
Generic: pioglitazone and glimepiride
Labeler: takeda pharmaceuticals america, inc.Drug Facts
Product Profile
Brand Name
duetact
Generic Name
pioglitazone and glimepiride
Labeler
takeda pharmaceuticals america, inc.
Dosage Form
TABLET
Routes
Active Ingredients
glimepiride 4 mg/1, pioglitazone hydrochloride 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
64764-304
Product ID
64764-304_23f68487-5d22-4618-9ccc-417aeb9fd3a8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA021925
Listing Expiration
2026-12-31
Marketing Start
2006-07-28
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
64764304
Hyphenated Format
64764-304
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
duetact (source: ndc)
Generic Name
pioglitazone and glimepiride (source: ndc)
Application Number
NDA021925 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
- 30 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (64764-304-30)
- 90 TABLET in 1 BOTTLE (64764-304-90)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "23f68487-5d22-4618-9ccc-417aeb9fd3a8", "openfda": {"nui": ["N0000175608", "M0020795"], "upc": ["0364764302306", "0364764304300"], "unii": ["JQT35NPK6C", "6KY687524K"], "rxcui": ["647237", "647239", "731457", "731463"], "spl_set_id": ["f8b0c917-3fdd-4a28-a47d-6225b8195458"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (64764-304-30)", "package_ndc": "64764-304-30", "marketing_start_date": "20060728"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (64764-304-90)", "package_ndc": "64764-304-90", "marketing_start_date": "20060728"}], "brand_name": "Duetact", "product_id": "64764-304_23f68487-5d22-4618-9ccc-417aeb9fd3a8", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Sulfonylurea Compounds [CS]", "Sulfonylurea [EPC]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "64764-304", "generic_name": "pioglitazone and glimepiride", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Duetact", "active_ingredients": [{"name": "GLIMEPIRIDE", "strength": "4 mg/1"}, {"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "NDA021925", "marketing_category": "NDA", "marketing_start_date": "20060728", "listing_expiration_date": "20261231"}